Core Scientific, Inc./tx
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $164.2M | $115.2M | $79.8M | $81.1M | $78.6M | $79.5M | $94.9M | $95.4M |
| Cost of Revenue | $94.2M | $85.1M | $59.0M | $77.2M | $73.6M | $71.3M | $90.2M | $95.5M |
| Gross Profit | $70.0M | $30.1M | $20.8M | $3.9M | $5.0M | $8.2M | $4.8M | $-156.0K |
| Gross Margin | 42.7% | 26.1% | 26.0% | 4.8% | 6.4% | 10.3% | 5.0% | -0.2% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | $5.0M | $2.8M |
| SG&A Expense | $49.4M | $44.8M | $12.3M | $69.4M | $45.3M | $32.3M | $25.0M | $40.3M |
| Operating Income | $-78.5M | $-310.4M | $-117.5M | $-54.8M | $-26.3M | $-47.0M | $-65.4M | $-41.2M |
| Operating Margin | -47.8% | -269.4% | -147.3% | -67.6% | -33.4% | -59.1% | -68.9% | -43.2% |
| Interest Expense | $40.6M | $8.2M | — | — | $4.8M | $4.7M | — | — |
| Pretax Income | $-1.15B | $-346.6M | $216.1M | $-143.9M | $-936.6M | $576.5M | $-290.8M | $-455.1M |
| Income Tax Expense | $1.9M | $600.0K | $95.0K | $125.0K | $158.0K | $205.0K | $375.0K | $134.0K |
| Net Income | $-1.16B | $-347.2M | $216.0M | $-144.0M | $-936.8M | $576.3M | $-291.1M | $-455.3M |
| Net Margin | -703.6% | -301.3% | 270.8% | -177.6% | -1,191.4% | 724.6% | -306.7% | -477.4% |
| EPS (Basic) | $-3.32 | $-1.06 | $-1.81 | $-0.45 | $-0.04 | $1.42 | $-0.69 | $-1.17 |
| EPS (Diluted) | $-3.32 | $-1.06 | $-1.63 | $-0.45 | $-0.04 | $1.24 | $-0.69 | $-1.17 |
| Shares Outstanding (Basic) | 325.3M | 322.9M | 318.1M | 318.6M | 318.0M | 315.2M | 255.8M | 292.5M |
| Shares Outstanding (Diluted) | 325.3M | 322.9M | 318.1M | 318.6M | 318.0M | 363.3M | 255.8M | 292.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |